藥物篩選&開發(fā)技術(shù)論壇 DSDT 2015將在上海召開
Drug Screening and Discovery Technologies Asian Forum 2015
Jan.21 (Wednesday) to Jan.22 (Thursday).2015
InterContinental Shanghai Pudong Hotel
Produced by: Deliver Consulting Limited
Supported by: Society for Laboratory Automation and Screening
Program Overview
The ‘Drug Screening and Discovery Technologies Asian Forum 2015’ is the annual forum produced by Deliver Consulting, exclusively focusing on the Asian concurrent screening and discovery technologies and innovation and is aiming to construct efficient dialogues for the improved scientific communication, partnership and is expecting invite over 35 keynote speakers and 200 senior scientists, Chief/Principal Investigators, R&D executives on target identification and validation; assay development and screening, library strategies and management, hit-to-lead exploration and early safety and efficacy assessment.
Program Key Discussions
► Target-based and Phenotypic Screening and Drug Discovery
► Functional Genomics and High Content Screening
► Natural Products Screening and Chemistry
► Screening Library Strategies, Virtual Screening and Library Management
► Novel Discovery Techniques and Assay Models
Confirmed Keynote Speakers
▪ Prof. Ming-Wei Wang, Director, The National Center for Drug Screening, CAS
▪ Prof. Li-Xin Zhang, Deputy Director, CAS Key Laboratory of Pathogenic Microbiology & Immunology; Inaugural Director for Drug Discovery Center for TB, Institute of Microbiology, CAS
▪ Prof. Baoxue Yang, Chair, Department of Pharmacology, School of Basic Medical Sciences, Peking University
▪ Prof. Wensheng Wei, Principal Investigator, College of Life Sciences, Peking University
▪ Prof. Lili Wang, Pharmacology Professor, Beijing Institute of Pharmacology and Toxicology
▪ Prof. Xulin Chen, Director, Antiviral Research Group, State Key Laboratory of Virology, Wuhan Institute of Virology, CAS
▪ Prof. Qing-Song Liu, Principal Investigator, Vice Director, Life Science Dept. High Magnetic Field Laboratory, CAS
▪ Prof. Jonathan Baell, Professor, MIPS, Monash University
▪ Prof. Hiroyuki Osada, Group Director, Chemical Biology Group, Deputy Director, Riken Center for Sustainable Resource Science
▪ Prof. Thomas Dick, Head, Antibacterial Drug Discovery Laboratory, The National University of Singapore
▪ Dr. Kurt Lackovic, Business and HTS Development Manager, The Walter + Eliza Hall Institute of Medical Research
▪ Prof. Ho-Jeong Kwon, Chairman, Dept. of Biotechnology, Yonsei University
▪ Prof. Seung-Bum Park, Director for Chemical Proteomics, Seoul National University
▪ Prof. Joon-Myong Song, Chair, Department of Pharmacy, Seoul National Unversity
▪ Dr. Kanury Rao, Head, Drug Discovery Research Centre, THSTI, Ministry of Science and Technology, Govt. of India
▪ Dr. Marc Bickle, Head, HT-Technology Development Studio, Max Planck Institute of Molecular Cell Biology and Genetics, Germany
▪ Dr. Zhiyuan Zhang, Director, Translational Research Center, NIBS
▪ Dr. Giridharan Periyasamy, Head, Centre for High Throughput Phenomics, Genome Institute of Singapore
▪ Prof. Meng-Ru Shen, Associate Dean for Research, Chair of Pharmacology, National Cheng Kung University
Please click here to review the up-to-date speaker panel and research focus.
Who Should Attend
Approx. 200 senior scientists, Chief/Principal Investigators, R&D executives are expected to attend 'Drug Screening and Discovery Technologies Asian Forum 2015', attracting a strong contingent throughout Asia Pacific, US and EU. The participants will mainly come from academia, research institutes, pharmaceutical and biotechnology companies and hospitals with the main responsibilities including but not limited to:
|
▪ Target Identification and Validation |
▪ Preclinical Development |
|
▪ Assay Development |
▪ ADME |
|
▪ Laboratory Automation |
▪ Medicinal Chemistry |
|
▪ Compound Profiling |
▪ Chemical Biology |
|
▪ High Content Analysis |
▪ Chemical Genomics |
|
▪ Cell Biology |
▪ Chemical Genetics |
|
▪ Natural Products Research |
▪ Biochemical/Cellular Assay |
|
▪ Stem Cell Research |
▪ Functional Genomics |
|
▪ Lead Generation |
▪ Compound Management |
Joining as a Delegate
Currently conference registration is available. Register before Nov.25. 2014, you will receive the reduced rate at CNY 5,000 / USD 820 for commercial organizations and CNY 3,500 / USD 575 for academia. Corporate will also enjoy considerable discounts by sending team to this conference.
Exhibiting and Supporting Opportunities
Exhibiting and supporting this screening forum is an effective measure to promote and reinforce your latest findings, cutting-edge products and services to a highly targeted group of key decision makers, scientists and end-users who are aiming to improve their assay development, screening and drug discovery productivity. These marketing and industry supporting opportunities also help committee to underwrite the cost of a service, program or incentive that we provide to conference attendees. Therefore, in addition to the branding recognition that you will receive, the committee also provides extra benefits to show our gratitude to those organizations of certain support levels.
Presenting a Poster
All attendees are encouraged to present a poster on the blackboard at site. The specification is A3 297 *420 mm, colorful with high resolution. All posters shall be printed out and carried by the registered organization.
For more information and enquiries about the latest forum agenda and speaking arrangement; attending, exhibiting and supporting options, please contact with:
Wei Zhang
Project Manager
86.21.6034.0229
- 瑞沃德將攜重磅新品亮相美國(guó)神經(jīng)科學(xué)學(xué)會(huì)年會(huì)SfN
- 東樂(lè)自然基因電生理儀器將參展CNS2024中國(guó)神經(jīng)大會(huì)
- 易科泰邀您參加中國(guó)昆蟲學(xué)會(huì)學(xué)術(shù)年會(huì)
- 預(yù)告—艾貝泰邀您參加細(xì)胞與基因治療第四屆年會(huì)
- 2025第44屆西部國(guó)際醫(yī)療器械展覽會(huì)通知
- 相約Medtec2024，睿度光電邀您共話生物芯片點(diǎn)樣技術(shù)
- 博普特成功參展2024年全國(guó)熱帶作物學(xué)術(shù)年會(huì)
- VIF World 2025第6屆疫苗創(chuàng)新國(guó)際論壇通知
- 進(jìn)科馳安邀您共聚第17屆中國(guó)神經(jīng)科學(xué)學(xué)會(huì)全國(guó)會(huì)議
- 博普特圓滿參展第二十一屆中國(guó)作物學(xué)會(huì)學(xué)術(shù)年會(huì)
- 會(huì)議：2024第23屆HUPO World Congress及PEAKS早餐會(huì)
- 南模生物邀您參加第八屆全國(guó)核酸疫苗大會(huì)
- 杭州大微受邀參加2024 IMic第十二屆工業(yè)微生物大會(huì)
- 羅輯科學(xué)精彩亮相2024年軍事病理學(xué)術(shù)會(huì)議
- IPHASE與您相約第十一次全國(guó)毒理學(xué)大會(huì)
- 天隆科技參與多病原核酸檢測(cè)重大科研項(xiàng)目正式啟動(dòng)
- 2024科華生物&天隆科技全國(guó)合作伙伴交流會(huì)成功舉辦
- 天隆參與起草的醫(yī)療機(jī)構(gòu)藥物基因檢測(cè)標(biāo)準(zhǔn)發(fā)布并實(shí)施
- 蘇州尚元醫(yī)療儀器產(chǎn)品免費(fèi)試用暨全國(guó)經(jīng)銷商招募
- 中食藥檢定研究院李靜莉等一行相關(guān)領(lǐng)導(dǎo)蒞臨天隆調(diào)研
- 天隆Panall 8000入選"中關(guān)村論壇"十大首發(fā)高端產(chǎn)品
- QIAGEN國(guó)產(chǎn)自動(dòng)化解決方案助力“煥新升級(jí)”
- 天隆核酸提取儀和定量PCR助力基層醫(yī)療服務(wù)能力提升
- 杭州奧盛新一代核酸提取儀Leap-Pure系列隆重上市
- 天隆參與制定國(guó)內(nèi)首個(gè)核酸提取設(shè)備醫(yī)藥行業(yè)標(biāo)準(zhǔn)
- 天隆科技VI標(biāo)識(shí)中環(huán)境標(biāo)識(shí)榮獲2023年美國(guó)繆斯設(shè)計(jì)獎(jiǎng)
- 天隆科技入選西安市生物醫(yī)藥“鏈主企業(yè)”名單
- Revvity推出病原體檢測(cè)解決方案快速應(yīng)對(duì)疾病傳播
- 天隆猴痘核酸檢測(cè)整體方案助力猴痘疫情防控
- 天隆創(chuàng)始人彭年才教授獲“突出貢獻(xiàn)人物”殊榮
Copyright(C) 1998-2024 生物器材網(wǎng) 電話：021-64166852;13621656896 E-mail：info@bio-equip.com